🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Megan E.V. Caram

University of Michigan

ORCID: 0000-0003-1597-5428

Also affiliated with VA Ann Arbor Healthcare System, VA Center for Clinical Management Research

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.748Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

Cancer(2023)10.1002/cncr.34916
Top 27%
0.748DataRank
Top 27%16 citations

David A. Elliott, Gillian Duchesne, Kristian Stensland, Megan E.V. Caram, Christina Chapman +8 more

Papers

Driven by 14 papers — median percentile 73. Top paper: “Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system”.

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

Cancer(2023)10.1002/cncr.34916
Top 27%
0.748DataRank
Top 27%16 citations

David A. Elliott, Gillian Duchesne, Kristian Stensland, Megan E.V. Caram, Christina Chapman +8 more

Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer

Implementation Science Communications(2021)10.1186/s43058-021-00224-8
N/A
0.607DataRank · unranked
24 citations

Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan E.V. Caram +11 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400
N/A
0.533DataRank · unranked
34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy

The Oncologist(2022)10.1093/oncolo/oyab033
N/A
0.483DataRank · unranked
24 citations

Ryan Ross, Amy S. B. Bohnert, Bhramar Mukherjee, Megan E.V. Caram, Phoebe A. Tsao

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

International Journal of Molecular Sciences(2021)10.3390/ijms23010004
N/A
0.396DataRank · unranked
13 citations

Tadas Kasputis, Srinivas Nallandhighal, Sophia M. Abusamra, Amy Kasputis, Saloni Haruray +12 more

EDITORIAL COMMENT

Urology(2023)10.1016/j.urology.2023.04.041
N/A
0DataRank · unranked
0 citations

Megan E.V. Caram, Kassem Faraj

Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitors

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae155
N/A
0DataRank · unranked
4 citations

Mary Oerline, Samuel R. Kaufman, Christopher Dall, Arnav Srivastava, Megan E.V. Caram +3 more

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing

Urology Practice(2024)10.1097/upj.0000000000000727
N/A
0DataRank · unranked
2 citations

Marissa A. Solorzano, Jake Quarles, Mallory Luke, Milan Patel, Randy Vince +15 more

Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.10.019
N/A
0DataRank · unranked
8 citations

Stephanie Daignault‐Newton, Petros Grivas, Zachery R. Reichert, Maha Hussain, Kathleen A. Cooney +9 more

Assessing the sex-based enrollment gap in urologic oncology clinical trials

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.016
N/A
0DataRank · unranked
0 citations

Merrick Bank, Stephanie Daignault‐Newton, Alice Semerjian, Belal Sbei, Rishi Sekar +11 more

Learning From the 'Tail End' of De-implementation: The Case of Chemical Castration for Localized Prostate Cancer

Research Square(2020)10.21203/rs.3.rs-132359/v1
N/A
0DataRank · unranked
1 citations

Jane Forman, Jordan B. Sparks, Tabitha Metreger, Sarah T. Hawley, Megan E.V. Caram +11 more

Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer

The Journal of Urology(2022)10.1097/ju.0000000000002865
N/A
0DataRank · unranked
13 citations

Marissa A. Solorzano, Mallory Luke, Jake Quarles, Michelle F. Jacobs, Sanjay Das +11 more

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac025
N/A
0DataRank · unranked
0 citations

Theresa P. Devasia, Megan E.V. Caram, Christina Chapman, A. Zaslavsky, Todd M. Morgan +8 more

National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer

Urology(2023)10.1016/j.urology.2023.10.018
N/A
0DataRank · unranked
18 citations

Megan E.V. Caram, Daniel J. Herr, Jennifer Burns, Jordan B. Sparks, David A. Elliott +7 more